NCT07574190Not yet recruiting
A Mobile Web App Intervention to Promote Cervical Cancer Screening
A Mobile Web App Intervention to Promote Cervical Cancer Screening Among Indigenous Women
Source: ClinicalTrials.gov · Last updated 22 May 2026
Brief summary (registry, in English)
The overarching goal of this study is to increase cervical cancer (CC) screening rates among Indigenous women in the U.S. Specifically, the study aims to develop and evaluate a culturally tailored, multilevel, multimedia mobile web app intervention (wPap) for women of the Yankton Sioux Tribe (YST) living on the YST Reservation in South Dakota. The wPap intervention will be tested in a randomized clinical trial (RCT) involving 120 YST women aged 25-65. Participants will be randomly assigned to either: (a) the wPap intervention group (n = 60), receiving personalized, culturally tailored multilevel multimedia messages through a mobile web app along with health navigator support, or (b) a waitlist control group (n = 60), receiving printed educational materials on cervical cancer and screening guidelines along with health navigator support. The intervention will last seven days, with assessments conducted at baseline, one week post-intervention, and six months post-intervention via surveys and telephone follow-up. The study tests the following hypotheses: (H1) women in the wPap intervention group will achieve higher CC screening rates than the waitlist control group; (H2) the wPap group will demonstrate greater improvements in knowledge, attitudes/beliefs, self-efficacy, and intention to undergo CC screening; and (H3) the wPap group will report higher satisfaction and acceptance of the intervention compared with the waitlist control group. Findings will inform the feasibility, acceptability, and efficacy of mobile web app interventions tailored to Indigenous communities to improve CC screening.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- First submitted
- 1 May 2026
- Start date
- 1 May 2026
- Primary completion date
- 30 Nov 2026
- Lead sponsor
- University of South Dakota
- Diseases
- Cervical cancer
- NCT number
- NCT07574190
What you commit to
- Study type: Interventional
- Planned participants: 120
- From 1 May 2026 to the primary completion date, 30 Nov 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Women with a prior diagnosis of cervical cancer
- Women with a previous colposcopy examination indicating abnormal cytology that requires more frequent screening than every 3 years
Other illness
- Women who are currently up to date with cervical cancer screening according to recommended guidelines (Pap test within the past 3 years, primary HPV testing within the past 5 years, or HPV/Pap co-testing within the past 5 years)
- Women who have had a total hysterectomy that included removal of the cervix, without a history of high-grade precancerous lesions
Age
- Women younger than 25 years or older than 65 years
Who the study is looking for
- Women who are self-identified AI women of the YST in SD
- Women who are aged 25 to 65 years
- Women who have not received any of the following cervical cancer screening tests: a Pap test within the past 3 years, primary HPV testing within the past 5 years, or HPV/Pap co-testing within the past 5 years.
- Women who are willing to use their own mobile phone, iPad, tablets, and computers, or a mobile phone borrowed from the research team for the wPap intervention.
Age in the registry: 25 years to 65 years · Sex: Female · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Yankton Sioux Tribe Coordinator of this site? Confirm its status | Lake Andes | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.